Evidence map›Paper›PMID 35296119›Full record

ArticleFrontiers in toxicology2020

Internal Threshold of Toxicological Concern (iTTC): Where We Are Today and What Is Possible in the Near Future.

Corie A Ellison, Anne Marie Api, Richard A Becker, Alina Y Efremenko, Sanket Gadhia, C Eric Hack, Nicola J Hewitt, Mustafa Varcin, Andreas Schepky

Abstract read
In one paragraph

Article in Frontiers in toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Developing an internal threshold of toxicological concern (iTTC).Journal of exposure science & environmental epidemiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Corie A EllisonThe Procter and Gamble Company, Cincinnati, OH, United States.
Anne Marie ApiResearch Institute for Fragrance Materials, Woodcliff Lake, NJ, United States.
Richard A BeckerAmerican Chemistry Council, Washington, DC, United States.
Alina Y EfremenkoScitoVation, Limited Liability Company (LLC), Durham, NC, United States.
Sanket GadhiaResearch Institute for Fragrance Materials, Woodcliff Lake, NJ, United States.
C Eric HackScitoVation, Limited Liability Company (LLC), Durham, NC, United States.
Nicola J HewittCosmetics Europe, Brussels, Belgium.
Mustafa VarcinCosmetics Europe, Brussels, Belgium.
Andreas SchepkyBeiersdorf AG, Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Threshold of Toxicological Concern (TTC) is a risk assessment tool for evaluating low-level exposure to chemicals with limited toxicological data. A next step in the ongoing development of TTC is to extend this concept further so that it can be applied to internal exposures. This refinement of TTC based on plasma concentrations, referred to as internal TTC (iTTC), attempts to convert the chemical-specific external NOAELs (in mg/kg/day) in the TTC database to an estimated internal exposure. A multi-stakeholder collaboration formed, with the aim of establishing an iTTC suitable for human safety risk assessment. Here, we discuss the advances and future directions for the iTTC project, including: (1) results from the systematic literature search for metabolism and pharmacokinetic data for the 1,251 chemicals in the iTTC database; (2) selection of ~350 chemicals that will be included in the final iTTC; (3) an overview of the

Indexed as

in vitro to in vivoITTCIVIVEmetabolismPBPKphysiologically based pharmacokinetic modelingthreshold of toxicological concernTTC

Identifiers

PMID35296119
PMCPMC8915896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.